The MAPK/ERK signaling pathway is an additional important target for inhibitors. This pathway is associated with managing cell differentiation, development, and survival. Inhibitors targeting MAPK/ERK are used in cancer therapies to prevent uncontrolled cell proliferation and lump development. Likewise, JAK/STAT signaling inhibitors modulate immune… Read More